[go: up one dir, main page]

CN1253508A - 局部鼻用抗炎组合物 - Google Patents

局部鼻用抗炎组合物 Download PDF

Info

Publication number
CN1253508A
CN1253508A CN98804579A CN98804579A CN1253508A CN 1253508 A CN1253508 A CN 1253508A CN 98804579 A CN98804579 A CN 98804579A CN 98804579 A CN98804579 A CN 98804579A CN 1253508 A CN1253508 A CN 1253508A
Authority
CN
China
Prior art keywords
composition
group
agent
nasal
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN98804579A
Other languages
English (en)
Chinese (zh)
Inventor
C·A·斯加尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Publication of CN1253508A publication Critical patent/CN1253508A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN98804579A 1997-04-30 1998-04-02 局部鼻用抗炎组合物 Pending CN1253508A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4430697P 1997-04-30 1997-04-30
US60/044,306 1997-04-30

Publications (1)

Publication Number Publication Date
CN1253508A true CN1253508A (zh) 2000-05-17

Family

ID=21931638

Family Applications (1)

Application Number Title Priority Date Filing Date
CN98804579A Pending CN1253508A (zh) 1997-04-30 1998-04-02 局部鼻用抗炎组合物

Country Status (8)

Country Link
EP (1) EP0979105A1 (fr)
JP (1) JP2001524108A (fr)
CN (1) CN1253508A (fr)
AU (1) AU6878098A (fr)
BR (1) BR9809022A (fr)
CA (1) CA2281789A1 (fr)
IL (1) IL131492A0 (fr)
WO (1) WO1998048839A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101128196B (zh) * 2005-03-16 2013-01-02 Meda制药有限及两合公司 用于治疗呼吸系统疾病的抗胆碱能药和白三烯受体拮抗剂的组合
CN104667256A (zh) * 2015-03-18 2015-06-03 江苏威克斯医疗科技有限公司 一种鼻腔粘膜纤毛护理冲洗液及其用途
CN107753485A (zh) * 2017-11-28 2018-03-06 赵永宏 一种兼有鼻减充血和麻醉作用的药物组合物及其应用

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2192781T3 (es) * 1997-08-26 2003-10-16 Aventis Pharma Inc Composicion farmaceutica para combinacion de piperidinoalcanol y un descongestivo.
WO1999032125A1 (fr) * 1997-12-23 1999-07-01 Schering Corporation Composition pour le traitement de maladies respiratoires et cutanees, comprenant au moins un antagoniste de leucotriene et au moins un antihistamine
US6384038B1 (en) * 1998-04-14 2002-05-07 Sepracor Inc. Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants
GB9822170D0 (en) * 1998-10-13 1998-12-02 Danbioyst Uk Ltd Novel formulations of fexofenadine
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
IT1313567B1 (it) * 1999-07-27 2002-09-09 Zambon Spa Uso della n-acetil-cisteina per la preparazione di composizionifarmaceutiche topiche per il trattamento di patologie allergiche delle
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
EA008165B1 (ru) 2001-09-18 2007-04-27 Никомед Данмарк Апс Композиции для лечения простуды
GB2389530B (en) * 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
TW200402307A (en) * 2002-06-20 2004-02-16 Novartis Consumer Health Sa Nasal composition
ATE472329T1 (de) 2002-08-30 2010-07-15 Nycomed Gmbh Verwendung der kombination von ciclesonid und antihistaminika zur behandlung von allergischer rhinitis
WO2005013963A1 (fr) * 2003-08-06 2005-02-17 Galephar M/F Combinaisons avantageuses pour inhalation de nacystelyn et de bronchodilatateurs
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
ES2704482T3 (es) 2004-11-24 2019-03-18 Meda Pharmaceuticals Inc Composiciones que comprenden azelastina y sus métodos de uso
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8093301B2 (en) * 2005-08-26 2012-01-10 Meiji Co., Ltd. Anti-allergic agent
AU2007272970C1 (en) * 2006-07-11 2013-01-10 Roy C. Levitt Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors
JP2008143845A (ja) * 2006-12-11 2008-06-26 Hoshienu Seiyaku Kk 点鼻薬組成物及び点鼻薬液噴霧器具
BR112014029442A2 (pt) * 2012-05-25 2017-06-27 Xlear Inc composições antimucosas à base de xilitol e métodos e composições relacionados

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3482015A (en) * 1965-02-08 1969-12-02 Merck & Co Inc Aerosol composition of phenylephrine tartrate and the production of such
US4053628A (en) * 1971-05-12 1977-10-11 Fisons Limited Composition
US4552899A (en) * 1984-04-09 1985-11-12 Analgesic Associates Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
JPH0753671B2 (ja) * 1985-12-26 1995-06-07 積水化学工業株式会社 経皮・経粘膜製剤
CA2122719A1 (fr) * 1991-11-19 1993-05-27 Jack M. Gwaltney, Jr. Traitement du rhume commun par l'antimediateur combine virostatique (covam)
AU7604094A (en) * 1993-09-07 1995-03-27 Procter & Gamble Company, The Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
WO1997001337A1 (fr) * 1995-06-29 1997-01-16 Mcneil-Ppc, Inc. Combinaison d'antihistamines et de steroides a application topique par voie nasale
AU6290396A (en) * 1995-06-29 1997-01-30 Mcneil-Ppc, Inc. The combination of topical nasal mast cell stabilizers and topical nasal steroids
DE19532714A1 (de) * 1995-09-05 1997-03-06 Bayer Ag Kombination von 5-Lipoxygenase- und Leukotriensynthese Inhibitoren mit Glucocorticosteroiden
EP0780127A1 (fr) * 1995-12-19 1997-06-25 The Procter & Gamble Company Pulvérisateur nasale contenant un stéréoide et un antihistamine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101128196B (zh) * 2005-03-16 2013-01-02 Meda制药有限及两合公司 用于治疗呼吸系统疾病的抗胆碱能药和白三烯受体拮抗剂的组合
CN104667256A (zh) * 2015-03-18 2015-06-03 江苏威克斯医疗科技有限公司 一种鼻腔粘膜纤毛护理冲洗液及其用途
CN107753485A (zh) * 2017-11-28 2018-03-06 赵永宏 一种兼有鼻减充血和麻醉作用的药物组合物及其应用

Also Published As

Publication number Publication date
CA2281789A1 (fr) 1998-11-05
JP2001524108A (ja) 2001-11-27
BR9809022A (pt) 2000-08-01
AU6878098A (en) 1998-11-24
WO1998048839A1 (fr) 1998-11-05
EP0979105A1 (fr) 2000-02-16
IL131492A0 (en) 2001-01-28

Similar Documents

Publication Publication Date Title
CN1253508A (zh) 局部鼻用抗炎组合物
US7867508B1 (en) Treatment of upper respiratory conditions
ES2369516T3 (es) Uso de furoato de mometasona para tratar enfermedades de las vías respiratorias y pulmonares.
ES2342463T3 (es) Formulacion superfina de formoterol.
US20090221541A1 (en) Pharmaceutical formulations
US20090238771A1 (en) Pharmaceutical formulations
KR20010052721A (ko) 급성 천식 질환의 예방 또는 치료를 위한 포르모테롤 및부데소니드를 포함하는 조성물의 용도
US20100144610A1 (en) Pharmaceutical formulations
US20240091148A1 (en) Eutectic solvents comprising pharmaceutical agents, and methods of making and use thereof
KR20140032936A (ko) 천식 치료에 사용되는 흡입용 복합 조성물
US11701426B2 (en) Non-infective nasal symptom management compositions and methods
ES2340777T3 (es) Metodo de tratamiento de la rinosinusitis aguda.
US20200121696A1 (en) Non-infective nasal symptom management compositions and methods
JP5154732B2 (ja) 薬剤
WO2020032910A1 (fr) Composition pharmaceutique, médicament et méthode de traitement de maladies bronchopulmonaires obstructives
Welch et al. A controlled trial of chlorofluorocarbon-free triamcinolone acetonide inhalation aerosol in the treatment of adult patients with persistent asthma
HK1027029A (en) Topical nasal antiinflammatory compositions
US20260048009A1 (en) Eutectic solvents comprising pharmaceutical agents, and methods of making and use thereof
TW589185B (en) Pharmaceutical compositions for treating sinusitis and otitis media comprising corticosteroids
MXPA99007597A (en) Topical nasal antiinflammatory compositions
US20070140978A1 (en) Adrenergic complement inhaler
EP3458156A1 (fr) Matériaux et procédés pour le traitement de la toux chronique
MXPA03007402A (es) Composiciones farmaceuticas y su envase, que contienen un esteroide para administracion intranasal.

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1027029

Country of ref document: HK